Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a system/content refresh. The core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-08-11T19:14:04.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor platform update rather than any changes to study details or content.
    Difference
    0.1%
    Check dated 2026-07-21T12:46:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page. This editorial update does not change the study details or outcomes.
    Difference
    0.1%
    Check dated 2026-06-30T00:37:23.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Recruitment status updated: Arms B and C are closed to enrollment, while Arm A remains open for enrollment.
    Difference
    0.4%
    Check dated 2026-06-15T18:20:14.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a site release update and does not modify trial information.
    Difference
    0.1%
    Check dated 2026-06-08T16:34:45.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This update appears to be a version label change rather than a substantive modification to the study content or results.
    Difference
    0.1%
    Check dated 2026-05-18T03:30:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.